Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Kairos Pharma Ltd’s stock clocked out at $0.69, up 9.35% from its previous closing price of $0.63. In other words, the price has increased by $9.35 from its previous closing price. On the day, 0.83 million shares were traded. KAPA stock price reached its highest trading level at $0.692 during the session, while it also had its lowest trading level at $0.6019.
Ratios:
To gain a deeper understanding of KAPA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.52 and its Current Ratio is at 7.52. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 25 ’24 when Murali Ramachandran bought 200 shares for $1.59 per share. The transaction valued at 318 led to the insider holds 133,057 shares of the business.
Samuelson Doug bought 2,500 shares of KAPA for $3,750 on Nov 22 ’24. The Chief Financial Officer now owns 60,796 shares after completing the transaction at $1.50 per share. On Nov 20 ’24, another insider, Yu John S, who serves as the CEO and Chairman of the company, bought 4,000 shares for $1.44 each. As a result, the insider paid 5,760 and bolstered with 5,341,837 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KAPA now has a Market Capitalization of 11626017 and an Enterprise Value of 8010021.
Stock Price History:
Over the past 52 weeks, KAPA has reached a high of $4.00, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is 1.96%, while the 200-Day Moving Average is calculated to be -44.21%.
Shares Statistics:
It appears that KAPA traded 784.73K shares on average per day over the past three months and 963140 shares per day over the past ten days. A total of 15.83M shares are outstanding, with a floating share count of 7.12M. Insiders hold about 57.73% of the company’s shares, while institutions hold 9.36% stake in the company. Shares short for KAPA as of 1749772800 were 192982 with a Short Ratio of 0.25, compared to 1747267200 on 85193. Therefore, it implies a Short% of Shares Outstanding of 192982 and a Short% of Float of 1.91.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The dynamic stock of Kairos Pharma Ltd (KAPA) is currently attracting attention from 1 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.05 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.19 and -$0.19 for the fiscal current year, implying an average EPS of -$0.19. EPS for the following year is -$0.4, with 1.0 analysts recommending between -$0.4 and -$0.4.
